Ophthalmology · Scottsdale, AZ
NPI
1467480749
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
13400 E Shea Blvd
Scottsdale, AZ, 85259
Phone (480) 301-8000
Groups this clinician bills Medicare through
Medicare paid, 2024
$168K
3,790 services
Medicare patients, 2024
496
Average age 76
Drug cost, 2024
$139K
986 prescriptions
Company payments, 2025
$616
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joanne Shen was code 99213 (office e&m - established), 519 times for 312 patients. In total Joanne Shen billed 3,790 services in 82 codes, and Medicare paid $168K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 519 | 312 | $65.06 | $34K |
| 68761 Eye | Office | 274 | 66 | $120.87 | $33K |
| 76514 Ultrasound - Nonspecific | Office | 247 | 148 | $7.82 | $1,932 |
| 67820 Eye | Office | 151 | 46 | $16.57 | $2,502 |
| 92133 Computerized Ophthalmic Imaging | Office | 109 | 102 | $24.06 | $2,623 |
| 99214 Office E&M - Established | Office | 93 | 81 | $87.58 | $8,145 |
| 99212 Office E&M - Established | Office | 90 | 55 | $43.22 | $3,890 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 78 | 73 | $12.37 | $965 |
| 92083 Vision, Hearing, and Speech Services | Office | 55 | 49 | $43.52 | $2,394 |
| 92012 Ophthalmological E&M | Office | 48 | 34 | $62.41 | $2,996 |
| 92285 Standard X-ray | Office | 40 | 33 | $16.86 | $674 |
| 66821 Cataract Surgery | Office | 38 | 27 | $251.07 | $9,541 |
| 99204 Office E&M - New | Office | 33 | 33 | $123.97 | $4,091 |
| 99215 Office E&M - Established | Office | 30 | 29 | $135.27 | $4,058 |
| 92014 Ophthalmological E&M | Office | 29 | 29 | $47.66 | $1,382 |
By year: 2022 $170K for 2,610 services; 2023 $149K for 3,137 services; 2024 $168K for 3,790 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83516 Immunoassay | 38 | 13 | $11.30 | $429 |
Medicare prescription drug claims, 2024
In 2024, the drug Joanne Shen prescribed most often to Medicare patients was Prednisolone Acetate, with 202 prescriptions and refills. In total Joanne Shen wrote 986 Medicare prescriptions that cost $139K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 202 | 371 | 83 | $8,627 |
| Moxifloxacin Moxifloxacin Hcl | 109 | 115 | 49 | $2,248 |
| Erythromycin Erythromycin Base | 78 | 80 | 35 | $947 |
| Timolol Maleate Generic | 57 | 94 | 16 | $522 |
| Latanoprost Generic | 43 | 99 | 15 | $330 |
| Ketorolac Tromethamine Generic | 39 | 50 | 21 | $1,051 |
| Fluorometholone Generic | 29 | 60 | 12 | $2,258 |
| Tobramycin Generic | 26 | 31 | 17 | $152 |
| Restasis Cyclosporine | 22 | 52 | Under 11 | $30K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 21 | 21 | 16 | $204 |
| Cyclosporine Generic | 20 | 34 | 11 | $8,939 |
| Loteprednol Etabonate Generic | 19 | 29 | Under 11 | $2,245 |
| Ofloxacin Generic | 18 | 22 | 15 | $256 |
| Doxycycline Monohydrate Generic | 18 | 46 | Under 11 | $550 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 18 | 19 | 13 | $861 |
Brand drugs: 427 claims; generic drugs: 559 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joanne Shen $616 ($616 in general payments such as food, travel and fees) from 5 companies. The largest payer was Abbvie Inc. with $147.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.